Talvinen K - Search Results

1

A prognostic model based on cell-cycle control predicts outcome of breast cancer patients.

Repo H, Löyttyniemi E, Kurki S, Kallio L, Kuopio T, Talvinen K, Kronqvist P. Repo H, et al. Among authors: talvinen k. BMC Cancer. 2020 Jun 16;20(1):558. doi: 10.1186/s12885-020-07045-3. BMC Cancer. 2020. PMID: 32546141 Free PMC article.

2

Securin promotes the identification of favourable outcome in invasive breast cancer.

Talvinen K, Karra H, Hurme S, Nykänen M, Nieminen A, Anttinen J, Kuopio T, Kronqvist P. Talvinen K, et al. Br J Cancer. 2009 Sep 15;101(6):1005-10. doi: 10.1038/sj.bjc.6605237. Epub 2009 Aug 18. Br J Cancer. 2009. PMID: 19690544 Free PMC article.

3

Altered expression of p120catenin predicts poor outcome in invasive breast cancer.

Talvinen K, Tuikkala J, Nykänen M, Nieminen A, Anttinen J, Nevalainen OS, Hurme S, Kuopio T, Kronqvist P. Talvinen K, et al. J Cancer Res Clin Oncol. 2010 Sep;136(9):1377-87. doi: 10.1007/s00432-010-0789-8. Epub 2010 Feb 12. J Cancer Res Clin Oncol. 2010. PMID: 20151151

4

Prognostic implications of securin expression and sub-cellular localization in human breast cancer.

Gurvits N, Repo H, Löyttyniemi E, Nykänen M, Anttinen J, Kuopio T, Talvinen K, Kronqvist P. Gurvits N, et al. Among authors: talvinen k. Cell Oncol (Dordr). 2016 Aug;39(4):319-31. doi: 10.1007/s13402-016-0277-5. Epub 2016 Mar 16. Cell Oncol (Dordr). 2016. PMID: 26984614

5

Tumor-infiltrating lymphocytes and CD8⁺ T cells predict survival of triple-negative breast cancer.

Vihervuori H, Autere TA, Repo H, Kurki S, Kallio L, Lintunen MM, Talvinen K, Kronqvist P. Vihervuori H, et al. Among authors: talvinen k. J Cancer Res Clin Oncol. 2019 Dec;145(12):3105-3114. doi: 10.1007/s00432-019-03036-5. Epub 2019 Sep 27. J Cancer Res Clin Oncol. 2019. PMID: 31562550 Free PMC article.

6

Securin predicts aneuploidy and survival in breast cancer.

Karra H, Pitkänen R, Nykänen M, Talvinen K, Kuopio T, Söderström M, Kronqvist P. Karra H, et al. Among authors: talvinen k. Histopathology. 2012 Mar;60(4):586-96. doi: 10.1111/j.1365-2559.2011.04107.x. Epub 2012 Jan 19. Histopathology. 2012. PMID: 22260438

7

Low cdc27 and high securin expression predict short survival for breast cancer patients.

Talvinen K, Karra H, Pitkänen R, Ahonen I, Nykänen M, Lintunen M, Söderström M, Kuopio T, Kronqvist P. Talvinen K, et al. APMIS. 2013 Oct;121(10):945-53. doi: 10.1111/apm.12110. Epub 2013 Jun 12. APMIS. 2013. PMID: 23755904

8

Separase is a marker for prognosis and mitotic activity in breast cancer.

Gurvits N, Löyttyniemi E, Nykänen M, Kuopio T, Kronqvist P, Talvinen K. Gurvits N, et al. Among authors: talvinen k. Br J Cancer. 2017 Oct 24;117(9):1383-1391. doi: 10.1038/bjc.2017.301. Epub 2017 Aug 31. Br J Cancer. 2017. PMID: 28859055 Free PMC article.

9

PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival.

Repo H, Gurvits N, Löyttyniemi E, Nykänen M, Lintunen M, Karra H, Kurki S, Kuopio T, Talvinen K, Söderström M, Kronqvist P. Repo H, et al. Among authors: talvinen k. BMC Cancer. 2017 Oct 27;17(1):705. doi: 10.1186/s12885-017-3694-6. BMC Cancer. 2017. PMID: 29078751 Free PMC article.

10

Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients.

Gurvits N, Autere TA, Repo H, Nykänen M, Kuopio T, Kronqvist P, Talvinen K. Gurvits N, et al. Among authors: talvinen k. J Cancer Res Clin Oncol. 2018 Apr;144(4):657-666. doi: 10.1007/s00432-018-2586-8. Epub 2018 Jan 23. J Cancer Res Clin Oncol. 2018. PMID: 29362919 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page